An assessment of adherence to the WHO-delineated good manufacturing practice by the pharmaceutical companies in Kabul, Afghanistan.

ABSTRACT:

Background

Afghanistan, a low-income landlocked country, is continuously suffering from domestic war and conflicts; the country struggles to provide quality healthcare services, including affordable medicinal products in the required quantity. Moreover, the quality standards of domestic pharmaceutical companies have not been established yet. One of the internationally recognized guidelines for monitoring manufacturing processes in pharmaceutical companies is Good Manufacturing Practice (GMP), recommended by World Health Organization (WHO). Therefore, this study aimed to assess whether a pharmaceutical company in Kabul, Afghanistan adheres to the GMP standards established by WHO.

Method

A descriptive cross-sectional study was conducted to assess the WHO-delineated GMP complia

SUBMITTER: Roien R 

PROVIDER: S-EPMC8977029 | biostudies-literature | 2022 Apr

REPOSITORIES: biostudies-literature